Bioretec for investors
Bioretec Ltd is a medical device company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The company develops, manufactures and commercializes innovative bioresorbable orthopedic implants and materials for bone and soft tissue injuries. Bioretec's products are used in approximately 40 countries, and the company continues to further research and develop materials and products for load-bearing clinical applications. The advantage of Bioretec's implants compared to traditional metal implants is that bioresorbable implants eliminate the need for implant removal operations that result in significant costs and may involve complications. Based in Tampere, Finland, Bioretec employs 24 dedicated professionals, supported by a top class Scientific Advisory Board with internationally recognized top-class surgeons as members.
Latest investment rounds
23 June 2021 Bioretec completed a 7,2 M€ equity funding round. Bioretec´s round was oversubscribed and ended during the first subscribtion day.
17 June 2021 Bioretec Ltd's Board of Directors decided to cancel the initial public offering announced on 4 June 2021. The Board of Directors has also decided to cancel the listing of the Company's shares on Nasdaq First North Growth Market Finland maintained by Nasdaq Helsinki Ltd.